カテゴリ： 世界, 医療/バイオ, Market Monitor Global

ヘパリンのグローバル市場展望 2023年-2029年：ナトリウム、カルシウム

■ 英語タイトル：Heparin Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14359）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14359
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：141
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ヘパリンのグローバル市場展望 2023年-2029年：ナトリウム、カルシウム]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のヘパリン市場規模と予測を収録しています。・世界のヘパリン市場：売上、2018年-2023年、2024年-2029年
・世界のヘパリン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のヘパリン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ナトリウム」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ヘパリンのグローバル主要企業は、Shenzhen Hepalink Pharmaceutical、 Yantai Dongcheng Pharmaceutical、 Pfizer、 Bioibérica、 Changzhou Qianhong Biopharma、 Nanjing King-friend Biochemical Pharmaceutical、 Hebei Changshan Biochemical Pharmaceutical、 Qingdao Jiulong Biopharmaceutical、 Opocrin、 Dongying Tiandong Pharmaceutical、 Aspen Oss、 Yino Pharma、 Nanjing Xinbai Pharmaceutical、 Hubei Enoray Biopharmaceutical、 Cisen Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ヘパリンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のヘパリン市場：タイプ別、2018年-2023年、2024年-2029年
世界のヘパリン市場：タイプ別市場シェア、2022年
・ナトリウム、カルシウム

世界のヘパリン市場：用途別、2018年-2023年、2024年-2029年
世界のヘパリン市場：用途別市場シェア、2022年
・UFH、LMWH

世界のヘパリン市場：地域・国別、2018年-2023年、2024年-2029年
世界のヘパリン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるヘパリンのグローバル売上、2018年-2023年
・主要企業におけるヘパリンのグローバル売上シェア、2022年
・主要企業におけるヘパリンのグローバル販売量、2018年-2023年
・主要企業におけるヘパリンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Shenzhen Hepalink Pharmaceutical、 Yantai Dongcheng Pharmaceutical、 Pfizer、 Bioibérica、 Changzhou Qianhong Biopharma、 Nanjing King-friend Biochemical Pharmaceutical、 Hebei Changshan Biochemical Pharmaceutical、 Qingdao Jiulong Biopharmaceutical、 Opocrin、 Dongying Tiandong Pharmaceutical、 Aspen Oss、 Yino Pharma、 Nanjing Xinbai Pharmaceutical、 Hubei Enoray Biopharmaceutical、 Cisen Pharmaceutical

*************************************************************

・調査・分析レポートの概要
ヘパリン市場の定義
市場セグメント
世界のヘパリン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のヘパリン市場規模
世界のヘパリン市場規模：2022年 VS 2029年
世界のヘパリン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのヘパリンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のヘパリン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ナトリウム、カルシウム
ヘパリンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：UFH、LMWH
ヘパリンの用途別グローバル売上・予測

・地域別市場分析
地域別ヘパリン市場規模 2022年と2029年
地域別ヘパリン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Shenzhen Hepalink Pharmaceutical、 Yantai Dongcheng Pharmaceutical、 Pfizer、 Bioibérica、 Changzhou Qianhong Biopharma、 Nanjing King-friend Biochemical Pharmaceutical、 Hebei Changshan Biochemical Pharmaceutical、 Qingdao Jiulong Biopharmaceutical、 Opocrin、 Dongying Tiandong Pharmaceutical、 Aspen Oss、 Yino Pharma、 Nanjing Xinbai Pharmaceutical、 Hubei Enoray Biopharmaceutical、 Cisen Pharmaceutical
...

This research report provides a comprehensive analysis of the Heparin market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Heparin market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Heparin, challenges faced by the industry, and potential opportunities for market players.
The global Heparin market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Heparin market presents opportunities for various stakeholders, including UFH, LMWH. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Heparin market. Additionally, the growing consumer demand present avenues for market expansion.
The global Heparin market was valued at US$ 2204.2 million in 2022 and is projected to reach US$ 2960.7 million by 2029, at a CAGR of 7.8% during the forecast period.
Global key players of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, etc. The top five manufacturers hold a share about 54%. China is dominating the global Heparin market, has a share over 65% in terms of production. Europe and Asia-Pacific are the two largest market, both having a share about 34%, followed by North America, with a share about 30 percent.
Key Features:
The research report on the Heparin market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Heparin market.
Market Overview: The report provides a comprehensive overview of the Heparin market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Heparin Sodium, Heparin Calcium), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Heparin market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Heparin market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Heparin market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Heparin market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Heparin market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Heparin market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Heparin, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Heparin market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Heparin market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Heparin Sodium
Heparin Calcium
Market segment by Application
UFH
LMWH
Global Heparin Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Pfizer
Bioibérica
Changzhou Qianhong Biopharma
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Opocrin
Dongying Tiandong Pharmaceutical
Aspen Oss
Yino Pharma
Nanjing Xinbai Pharmaceutical
Hubei Enoray Biopharmaceutical
Cisen Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Heparin, market overview.
Chapter 2: Global Heparin market size in revenue and volume.
Chapter 3: Detailed analysis of Heparin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Heparin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Heparin capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Heparin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Heparin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Heparin Overall Market Size
2.1 Global Heparin Market Size: 2022 VS 2029
2.2 Global Heparin Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Heparin Sales: 2018-2029
3 Company Landscape
3.1 Top Heparin Players in Global Market
3.2 Top Global Heparin Companies Ranked by Revenue
3.3 Global Heparin Revenue by Companies
3.4 Global Heparin Sales by Companies
3.5 Global Heparin Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Heparin Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Heparin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Heparin Players in Global Market
3.8.1 List of Global Tier 1 Heparin Companies
3.8.2 List of Global Tier 2 and Tier 3 Heparin Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Heparin Market Size Markets, 2022 & 2029
4.1.2 Heparin Sodium
4.1.3 Heparin Calcium
4.2 By Type – Global Heparin Revenue & Forecasts
4.2.1 By Type – Global Heparin Revenue, 2018-2023
4.2.2 By Type – Global Heparin Revenue, 2024-2029
4.2.3 By Type – Global Heparin Revenue Market Share, 2018-2029
4.3 By Type – Global Heparin Sales & Forecasts
4.3.1 By Type – Global Heparin Sales, 2018-2023
4.3.2 By Type – Global Heparin Sales, 2024-2029
4.3.3 By Type – Global Heparin Sales Market Share, 2018-2029
4.4 By Type – Global Heparin Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Heparin Market Size, 2022 & 2029
5.1.2 UFH
5.1.3 LMWH
5.2 By Application – Global Heparin Revenue & Forecasts
5.2.1 By Application – Global Heparin Revenue, 2018-2023
5.2.2 By Application – Global Heparin Revenue, 2024-2029
5.2.3 By Application – Global Heparin Revenue Market Share, 2018-2029
5.3 By Application – Global Heparin Sales & Forecasts
5.3.1 By Application – Global Heparin Sales, 2018-2023
5.3.2 By Application – Global Heparin Sales, 2024-2029
5.3.3 By Application – Global Heparin Sales Market Share, 2018-2029
5.4 By Application – Global Heparin Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Heparin Market Size, 2022 & 2029
6.2 By Region – Global Heparin Revenue & Forecasts
6.2.1 By Region – Global Heparin Revenue, 2018-2023
6.2.2 By Region – Global Heparin Revenue, 2024-2029
6.2.3 By Region – Global Heparin Revenue Market Share, 2018-2029
6.3 By Region – Global Heparin Sales & Forecasts
6.3.1 By Region – Global Heparin Sales, 2018-2023
6.3.2 By Region – Global Heparin Sales, 2024-2029
6.3.3 By Region – Global Heparin Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Heparin Revenue, 2018-2029
6.4.2 By Country – North America Heparin Sales, 2018-2029
6.4.3 US Heparin Market Size, 2018-2029
6.4.4 Canada Heparin Market Size, 2018-2029
6.4.5 Mexico Heparin Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Heparin Revenue, 2018-2029
6.5.2 By Country – Europe Heparin Sales, 2018-2029
6.5.3 Germany Heparin Market Size, 2018-2029
6.5.4 France Heparin Market Size, 2018-2029
6.5.5 U.K. Heparin Market Size, 2018-2029
6.5.6 Italy Heparin Market Size, 2018-2029
6.5.7 Russia Heparin Market Size, 2018-2029
6.5.8 Nordic Countries Heparin Market Size, 2018-2029
6.5.9 Benelux Heparin Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Heparin Revenue, 2018-2029
6.6.2 By Region – Asia Heparin Sales, 2018-2029
6.6.3 China Heparin Market Size, 2018-2029
6.6.4 Japan Heparin Market Size, 2018-2029
6.6.5 South Korea Heparin Market Size, 2018-2029
6.6.6 Southeast Asia Heparin Market Size, 2018-2029
6.6.7 India Heparin Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Heparin Revenue, 2018-2029
6.7.2 By Country – South America Heparin Sales, 2018-2029
6.7.3 Brazil Heparin Market Size, 2018-2029
6.7.4 Argentina Heparin Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Heparin Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Heparin Sales, 2018-2029
6.8.3 Turkey Heparin Market Size, 2018-2029
6.8.4 Israel Heparin Market Size, 2018-2029
6.8.5 Saudi Arabia Heparin Market Size, 2018-2029
6.8.6 UAE Heparin Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Shenzhen Hepalink Pharmaceutical
7.1.1 Shenzhen Hepalink Pharmaceutical Company Summary
7.1.2 Shenzhen Hepalink Pharmaceutical Business Overview
7.1.3 Shenzhen Hepalink Pharmaceutical Heparin Major Product Offerings
7.1.4 Shenzhen Hepalink Pharmaceutical Heparin Sales and Revenue in Global (2018-2023)
7.1.5 Shenzhen Hepalink Pharmaceutical Key News & Latest Developments
7.2 Yantai Dongcheng Pharmaceutical
7.2.1 Yantai Dongcheng Pharmaceutical Company Summary
7.2.2 Yantai Dongcheng Pharmaceutical Business Overview
7.2.3 Yantai Dongcheng Pharmaceutical Heparin Major Product Offerings
7.2.4 Yantai Dongcheng Pharmaceutical Heparin Sales and Revenue in Global (2018-2023)
7.2.5 Yantai Dongcheng Pharmaceutical Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Heparin Major Product Offerings
7.3.4 Pfizer Heparin Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Bioibérica
7.4.1 Bioibérica Company Summary
7.4.2 Bioibérica Business Overview
7.4.3 Bioibérica Heparin Major Product Offerings
7.4.4 Bioibérica Heparin Sales and Revenue in Global (2018-2023)
7.4.5 Bioibérica Key News & Latest Developments
7.5 Changzhou Qianhong Biopharma
7.5.1 Changzhou Qianhong Biopharma Company Summary
7.5.2 Changzhou Qianhong Biopharma Business Overview
7.5.3 Changzhou Qianhong Biopharma Heparin Major Product Offerings
7.5.4 Changzhou Qianhong Biopharma Heparin Sales and Revenue in Global (2018-2023)
7.5.5 Changzhou Qianhong Biopharma Key News & Latest Developments
7.6 Nanjing King-friend Biochemical Pharmaceutical
7.6.1 Nanjing King-friend Biochemical Pharmaceutical Company Summary
7.6.2 Nanjing King-friend Biochemical Pharmaceutical Business Overview
7.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Major Product Offerings
7.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales and Revenue in Global (2018-2023)
7.6.5 Nanjing King-friend Biochemical Pharmaceutical Key News & Latest Developments
7.7 Hebei Changshan Biochemical Pharmaceutical
7.7.1 Hebei Changshan Biochemical Pharmaceutical Company Summary
7.7.2 Hebei Changshan Biochemical Pharmaceutical Business Overview
7.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin Major Product Offerings
7.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin Sales and Revenue in Global (2018-2023)
7.7.5 Hebei Changshan Biochemical Pharmaceutical Key News & Latest Developments
7.8 Qingdao Jiulong Biopharmaceutical
7.8.1 Qingdao Jiulong Biopharmaceutical Company Summary
7.8.2 Qingdao Jiulong Biopharmaceutical Business Overview
7.8.3 Qingdao Jiulong Biopharmaceutical Heparin Major Product Offerings
7.8.4 Qingdao Jiulong Biopharmaceutical Heparin Sales and Revenue in Global (2018-2023)
7.8.5 Qingdao Jiulong Biopharmaceutical Key News & Latest Developments
7.9 Opocrin
7.9.1 Opocrin Company Summary
7.9.2 Opocrin Business Overview
7.9.3 Opocrin Heparin Major Product Offerings
7.9.4 Opocrin Heparin Sales and Revenue in Global (2018-2023)
7.9.5 Opocrin Key News & Latest Developments
7.10 Dongying Tiandong Pharmaceutical
7.10.1 Dongying Tiandong Pharmaceutical Company Summary
7.10.2 Dongying Tiandong Pharmaceutical Business Overview
7.10.3 Dongying Tiandong Pharmaceutical Heparin Major Product Offerings
7.10.4 Dongying Tiandong Pharmaceutical Heparin Sales and Revenue in Global (2018-2023)
7.10.5 Dongying Tiandong Pharmaceutical Key News & Latest Developments
7.11 Aspen Oss
7.11.1 Aspen Oss Company Summary
7.11.2 Aspen Oss Business Overview
7.11.3 Aspen Oss Heparin Major Product Offerings
7.11.4 Aspen Oss Heparin Sales and Revenue in Global (2018-2023)
7.11.5 Aspen Oss Key News & Latest Developments
7.12 Yino Pharma
7.12.1 Yino Pharma Company Summary
7.12.2 Yino Pharma Business Overview
7.12.3 Yino Pharma Heparin Major Product Offerings
7.12.4 Yino Pharma Heparin Sales and Revenue in Global (2018-2023)
7.12.5 Yino Pharma Key News & Latest Developments
7.13 Nanjing Xinbai Pharmaceutical
7.13.1 Nanjing Xinbai Pharmaceutical Company Summary
7.13.2 Nanjing Xinbai Pharmaceutical Business Overview
7.13.3 Nanjing Xinbai Pharmaceutical Heparin Major Product Offerings
7.13.4 Nanjing Xinbai Pharmaceutical Heparin Sales and Revenue in Global (2018-2023)
7.13.5 Nanjing Xinbai Pharmaceutical Key News & Latest Developments
7.14 Hubei Enoray Biopharmaceutical
7.14.1 Hubei Enoray Biopharmaceutical Company Summary
7.14.2 Hubei Enoray Biopharmaceutical Business Overview
7.14.3 Hubei Enoray Biopharmaceutical Heparin Major Product Offerings
7.14.4 Hubei Enoray Biopharmaceutical Heparin Sales and Revenue in Global (2018-2023)
7.14.5 Hubei Enoray Biopharmaceutical Key News & Latest Developments
7.15 Cisen Pharmaceutical
7.15.1 Cisen Pharmaceutical Company Summary
7.15.2 Cisen Pharmaceutical Business Overview
7.15.3 Cisen Pharmaceutical Heparin Major Product Offerings
7.15.4 Cisen Pharmaceutical Heparin Sales and Revenue in Global (2018-2023)
7.15.5 Cisen Pharmaceutical Key News & Latest Developments
8 Global Heparin Production Capacity, Analysis
8.1 Global Heparin Production Capacity, 2018-2029
8.2 Heparin Production Capacity of Key Manufacturers in Global Market
8.3 Global Heparin Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Heparin Supply Chain Analysis
10.1 Heparin Industry Value Chain
10.2 Heparin Upstream Market
10.3 Heparin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Heparin Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Heparin in Global Market
Table 2. Top Heparin Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Heparin Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Heparin Revenue Share by Companies, 2018-2023
Table 5. Global Heparin Sales by Companies, (B Units), 2018-2023
Table 6. Global Heparin Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Heparin Price (2018-2023) & (US$/B Units)
Table 8. Global Manufacturers Heparin Product Type
Table 9. List of Global Tier 1 Heparin Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Heparin Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Heparin Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Heparin Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Heparin Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Heparin Sales (B Units), 2018-2023
Table 15. By Type - Global Heparin Sales (B Units), 2024-2029
Table 16. By Application – Global Heparin Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Heparin Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Heparin Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Heparin Sales (B Units), 2018-2023
Table 20. By Application - Global Heparin Sales (B Units), 2024-2029
Table 21. By Region – Global Heparin Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Heparin Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Heparin Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Heparin Sales (B Units), 2018-2023
Table 25. By Region - Global Heparin Sales (B Units), 2024-2029
Table 26. By Country - North America Heparin Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Heparin Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Heparin Sales, (B Units), 2018-2023
Table 29. By Country - North America Heparin Sales, (B Units), 2024-2029
Table 30. By Country - Europe Heparin Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Heparin Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Heparin Sales, (B Units), 2018-2023
Table 33. By Country - Europe Heparin Sales, (B Units), 2024-2029
Table 34. By Region - Asia Heparin Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Heparin Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Heparin Sales, (B Units), 2018-2023
Table 37. By Region - Asia Heparin Sales, (B Units), 2024-2029
Table 38. By Country - South America Heparin Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Heparin Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Heparin Sales, (B Units), 2018-2023
Table 41. By Country - South America Heparin Sales, (B Units), 2024-2029
Table 42. By Country - Middle East & Africa Heparin Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Heparin Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Heparin Sales, (B Units), 2018-2023
Table 45. By Country - Middle East & Africa Heparin Sales, (B Units), 2024-2029
Table 46. Shenzhen Hepalink Pharmaceutical Company Summary
Table 47. Shenzhen Hepalink Pharmaceutical Heparin Product Offerings
Table 48. Shenzhen Hepalink Pharmaceutical Heparin Sales (B Units), Revenue (US$, Mn) and Average Price (US$/B Units) (2018-2023)
Table 49. Shenzhen Hepalink Pharmaceutical Key News & Latest Developments
Table 50. Yantai Dongcheng Pharmaceutical Company Summary
Table 51. Yantai Dongcheng Pharmaceutical Heparin Product Offerings
Table 52. Yantai Dongcheng Pharmaceutical Heparin Sales (B Units), Revenue (US$, Mn) and Average Price (US$/B Units) (2018-2023)
Table 53. Yantai Dongcheng Pharmaceutical Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Heparin Product Offerings
Table 56. Pfizer Heparin Sales (B Units), Revenue (US$, Mn) and Average Price (US$/B Units) (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Bioibérica Company Summary
Table 59. Bioibérica Heparin Product Offerings
Table 60. Bioibérica Heparin Sales (B Units), Revenue (US$, Mn) and Average Price (US$/B Units) (2018-2023)
Table 61. Bioibérica Key News & Latest Developments
Table 62. Changzhou Qianhong Biopharma Company Summary
Table 63. Changzhou Qianhong Biopharma Heparin Product Offerings
Table 64. Changzhou Qianhong Biopharma Heparin Sales (B Units), Revenue (US$, Mn) and Average Price (US$/B Units) (2018-2023)
Table 65. Changzhou Qianhong Biopharma Key News & Latest Developments
Table 66. Nanjing King-friend Biochemical Pharmaceutical Company Summary
Table 67. Nanjing King-friend Biochemical Pharmaceutical Heparin Product Offerings
Table 68. Nanjing King-friend Biochemical Pharmaceutical Heparin Sales (B Units), Revenue (US$, Mn) and Average Price (US$/B Units) (2018-2023)
Table 69. Nanjing King-friend Biochemical Pharmaceutical Key News & Latest Developments
Table 70. Hebei Changshan Biochemical Pharmaceutical Company Summary
Table 71. Hebei Changshan Biochemical Pharmaceutical Heparin Product Offerings
Table 72. Hebei Changshan Biochemical Pharmaceutical Heparin Sales (B Units), Revenue (US$, Mn) and Average Price (US$/B Units) (2018-2023)
Table 73. Hebei Changshan Biochemical Pharmaceutical Key News & Latest Developments
Table 74. Qingdao Jiulong Biopharmaceutical Company Summary
Table 75. Qingdao Jiulong Biopharmaceutical Heparin Product Offerings
Table 76. Qingdao Jiulong Biopharmaceutical Heparin Sales (B Units), Revenue (US$, Mn) and Average Price (US$/B Units) (2018-2023)
Table 77. Qingdao Jiulong Biopharmaceutical Key News & Latest Developments
Table 78. Opocrin Company Summary
Table 79. Opocrin Heparin Product Offerings
Table 80. Opocrin Heparin Sales (B Units), Revenue (US$, Mn) and Average Price (US$/B Units) (2018-2023)
Table 81. Opocrin Key News & Latest Developments
Table 82. Dongying Tiandong Pharmaceutical Company Summary
Table 83. Dongying Tiandong Pharmaceutical Heparin Product Offerings
Table 84. Dongying Tiandong Pharmaceutical Heparin Sales (B Units), Revenue (US$, Mn) and Average Price (US$/B Units) (2018-2023)
Table 85. Dongying Tiandong Pharmaceutical Key News & Latest Developments
Table 86. Aspen Oss Company Summary
Table 87. Aspen Oss Heparin Product Offerings
Table 88. Aspen Oss Heparin Sales (B Units), Revenue (US$, Mn) and Average Price (US$/B Units) (2018-2023)
Table 89. Aspen Oss Key News & Latest Developments
Table 90. Yino Pharma Company Summary
Table 91. Yino Pharma Heparin Product Offerings
Table 92. Yino Pharma Heparin Sales (B Units), Revenue (US$, Mn) and Average Price (US$/B Units) (2018-2023)
Table 93. Yino Pharma Key News & Latest Developments
Table 94. Nanjing Xinbai Pharmaceutical Company Summary
Table 95. Nanjing Xinbai Pharmaceutical Heparin Product Offerings
Table 96. Nanjing Xinbai Pharmaceutical Heparin Sales (B Units), Revenue (US$, Mn) and Average Price (US$/B Units) (2018-2023)
Table 97. Nanjing Xinbai Pharmaceutical Key News & Latest Developments
Table 98. Hubei Enoray Biopharmaceutical Company Summary
Table 99. Hubei Enoray Biopharmaceutical Heparin Product Offerings
Table 100. Hubei Enoray Biopharmaceutical Heparin Sales (B Units), Revenue (US$, Mn) and Average Price (US$/B Units) (2018-2023)
Table 101. Hubei Enoray Biopharmaceutical Key News & Latest Developments
Table 102. Cisen Pharmaceutical Company Summary
Table 103. Cisen Pharmaceutical Heparin Product Offerings
Table 104. Cisen Pharmaceutical Heparin Sales (B Units), Revenue (US$, Mn) and Average Price (US$/B Units) (2018-2023)
Table 105. Cisen Pharmaceutical Key News & Latest Developments
Table 106. Heparin Production Capacity (B Units) of Key Manufacturers in Global Market, 2021-2023 (B Units)
Table 107. Global Heparin Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Heparin Production by Region, 2018-2023 (B Units)
Table 109. Global Heparin Production by Region, 2024-2029 (B Units)
Table 110. Heparin Market Opportunities & Trends in Global Market
Table 111. Heparin Market Drivers in Global Market
Table 112. Heparin Market Restraints in Global Market
Table 113. Heparin Raw Materials
Table 114. Heparin Raw Materials Suppliers in Global Market
Table 115. Typical Heparin Downstream
Table 116. Heparin Downstream Clients in Global Market
Table 117. Heparin Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Heparin Segment by Type in 2022
Figure 2. Heparin Segment by Application in 2022
Figure 3. Global Heparin Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Heparin Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Heparin Revenue, 2018-2029 (US$, Mn)
Figure 7. Heparin Sales in Global Market: 2018-2029 (B Units)
Figure 8. The Top 3 and 5 Players Market Share by Heparin Revenue in 2022
Figure 9. By Type - Global Heparin Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Heparin Revenue Market Share, 2018-2029
Figure 11. By Type - Global Heparin Sales Market Share, 2018-2029
Figure 12. By Type - Global Heparin Price (US$/B Units), 2018-2029
Figure 13. By Application - Global Heparin Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Heparin Revenue Market Share, 2018-2029
Figure 15. By Application - Global Heparin Sales Market Share, 2018-2029
Figure 16. By Application - Global Heparin Price (US$/B Units), 2018-2029
Figure 17. By Region - Global Heparin Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Heparin Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Heparin Revenue Market Share, 2018-2029
Figure 20. By Region - Global Heparin Sales Market Share, 2018-2029
Figure 21. By Country - North America Heparin Revenue Market Share, 2018-2029
Figure 22. By Country - North America Heparin Sales Market Share, 2018-2029
Figure 23. US Heparin Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Heparin Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Heparin Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Heparin Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Heparin Sales Market Share, 2018-2029
Figure 28. Germany Heparin Revenue, (US$, Mn), 2018-2029
Figure 29. France Heparin Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Heparin Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Heparin Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Heparin Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Heparin Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Heparin Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Heparin Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Heparin Sales Market Share, 2018-2029
Figure 37. China Heparin Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Heparin Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Heparin Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Heparin Revenue, (US$, Mn), 2018-2029
Figure 41. India Heparin Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Heparin Revenue Market Share, 2018-2029
Figure 43. By Country - South America Heparin Sales Market Share, 2018-2029
Figure 44. Brazil Heparin Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Heparin Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Heparin Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Heparin Sales Market Share, 2018-2029
Figure 48. Turkey Heparin Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Heparin Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Heparin Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Heparin Revenue, (US$, Mn), 2018-2029
Figure 52. Global Heparin Production Capacity (B Units), 2018-2029
Figure 53. The Percentage of Production Heparin by Region, 2022 VS 2029
Figure 54. Heparin Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ヘパリンコート眼内レンズのグローバル市場展望 2023年-2029年：プレロード眼内レンズ、非プレロード眼内レンズ
  • 製薬契約×組織のグローバル市場展望 2023年-2029年：CRO、CMO/CDMO
  • 医薬品用滅菌機のグローバル市場展望 2023年-2029年：手動式、自動式
  • 医薬品用ビタミンAのグローバル市場展望 2023年-2029年：低純度飼料用ビタミンA、高純度飼料用ビタミンA
  • OTC片頭痛薬のグローバル市場展望 2023年-2029年：NSAIDs、アセトアミノフェン、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14359 )"ヘパリンのグローバル市場展望 2023年-2029年：ナトリウム、カルシウム" (英文：Heparin Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。